These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28056798)

  • 1. High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele.
    Bagyura Z; Kiss L; Berta B; Szilágyi Á; Hirschberg K; Széplaki G; Lux Á; Szelid Z; Soós P; Merkely B
    BMC Cardiovasc Disord; 2017 Jan; 17(1):4. PubMed ID: 28056798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.
    Li Y; Chen F; Zhang X; Gao Y; Wu C; Li H; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(6):7350-7. PubMed ID: 26261635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
    Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
    Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.
    Bagyura Z; Kiss L; Hirschberg K; Berta B; Széplaki G; Lux Á; Szelid Z; Soós P; Merkely B
    Dis Markers; 2017; 2017():9548612. PubMed ID: 28484288
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic risk of restenosis after percutaneous coronary interventions in the era of drug-eluting stents.
    Hoppmann P; Koch W; Laugwitz KL; Kastrati A
    Coron Artery Dis; 2014 Dec; 25(8):658-64. PubMed ID: 25025995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A; Tekiner F; Karakurt A; Sirin G; Duman D
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study.
    Pleva L; Kukla P; Kusnierova P; Zapletalova J; Hlinomaz O
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003316. PubMed ID: 27069104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Gene Polymorphisms/Haplotypes and Plasma Level of TGF-β1 in Susceptibility to In-Stent Restenosis Following Coronary Implantation of Bare Metal Stent in Chinese Han Patients.
    Chen HJ; Mo N; Zhang YF; Su GZ; Wu HD; Pei F
    Int Heart J; 2018 Jan; 59(1):161-169. PubMed ID: 29332922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA; Minha S; Chen F; Torguson R; Omar AF; Loh JP; Escarcega RO; Lipinski MJ; Baker NC; Kitabata H; Ota H; Suddath WO; Satler LF; Pichard AD; Waksman R
    Circ Cardiovasc Interv; 2014 Dec; 7(6):768-76. PubMed ID: 25466551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG; Kang SJ; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2014 May; 83(6):873-8. PubMed ID: 22815193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.
    Kessler T; Wolf B; Eriksson N; Kofink D; Mahmoodi BK; Rai H; Tragante V; Åkerblom A; Becker RC; Bernlochner I; Bopp R; James S; Katus HA; Mayer K; Munz M; Nordio F; O'Donoghue ML; Sager HB; Sibbing D; Solakov L; Storey RF; Wobst J; Asselbergs FW; Byrne RA; Erdmann J; Koenig W; Laugwitz KL; Ten Berg JM; Wallentin L; Kastrati A; Schunkert H
    Cardiovasc Res; 2019 Aug; 115(10):1512-1518. PubMed ID: 30768153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of successful manual thrombus aspiration on in-stent restenosis after primary PCI: angiographic and clinical follow-up.
    Bulum J; Ernst A; Strozzi M
    Coron Artery Dis; 2012 Nov; 23(7):487-91. PubMed ID: 22936018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bare-metal stent versus drug-eluting stent in large coronary arteries: meta-analysis of randomized controlled trials.
    Geng DF; Meng Z; Yan HY; Nie RQ; Deng J; Wang JF
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1087-94. PubMed ID: 22899538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.